Interacting Drugs |
Ketorolac (systemic) vs CycloSPORINE |
Security Level |
|
Mechanism |
CycloSPORINE: Nonsteroidal Anti-Inflammatory Agents may enhance the nephrotoxic effect of CycloSPORINE. Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of CycloSPORINE. |
Management |
Consider therapy modification |
Ketorolac (systemic) vs CycloSPORINE
Post Review about Ketorolac (systemic) vs CycloSPORINE Click here to cancel reply.
Other Interactions of Ketorolac (systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.